Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/06/2008US7368120 Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
05/06/2008US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents
05/06/2008US7368102 Pulmonary delivery of aminoglycosides
05/06/2008US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same
05/06/2008CA2609766A1 Product for the management of inflammations, pressure sores and/or oral sores (aphthas) as well as the use of such product
05/06/2008CA2468679C Antibiotic formulation and a method of making this formulation
05/06/2008CA2463619C Stabilized azithromycin compositions
05/06/2008CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
05/06/2008CA2430601C Piperazine derivatives
05/06/2008CA2400133C Anaesthetic composition
05/06/2008CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid
05/06/2008CA2390649C 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
05/06/2008CA2380078C Combination therapy using pentafluorobenzenesulfonamides
05/06/2008CA2378987C A binder for pharmaceutical compositions
05/06/2008CA2377803C Phenyl sulfamate derivatives
05/06/2008CA2376780C Intraocular tension lowering compositions for topical administration
05/06/2008CA2368370C The use of dienogest in high dosages
05/06/2008CA2345675C Two chamber cartridge for atomizers
05/06/2008CA2327468C Semi-synthetic ecteinascidins
05/06/2008CA2322878C Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
05/06/2008CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity
05/06/2008CA2311311C Biodegradable intra vaginal devices
05/06/2008CA2310230C The use of brinzolamide to prevent visual field loss
05/06/2008CA2294352C Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6] cyclohepta[1,2-b]pyridine
05/06/2008CA2283868C Photosensitizer conjugates for pathogen targeting
05/06/2008CA2280727C Bicyclic amino acids
05/06/2008CA2279795C Methods of making an emulsified composition
05/06/2008CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
05/06/2008CA2239694C Indane dimer compounds and their pharmaceutical use
05/06/2008CA2237763C Production of a salt of clavulanic acid
05/06/2008CA2217821C Benzopyrans and pharmaceutical compositions containing them
05/02/2008WO2008052190A2 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
05/02/2008WO2008052189A2 Micropore delivery of active substances
05/02/2008WO2008052183A2 Therapeutic compositions and methods of treatment with capsianoside-type compounds
05/02/2008WO2008052139A2 Ultra low dose doxepin and methods of using the same to treat sleep disorders
05/02/2008WO2008052115A1 Materials and methods for predicting physiological responses to cardiovascular drugs
05/02/2008WO2008052088A1 Chromane derivatives, synthesis thereof, and intermediates thereto
05/02/2008WO2008052087A1 Chromane derivatives and uses thereof
05/02/2008WO2008052086A1 Benzodioxane derivatives and uses thereof
05/02/2008WO2008052078A2 Benzoxathiine and benzoxathiole derivatives and uses thereof
05/02/2008WO2008052075A2 Benzoxazine derivatives and uses thereof
05/02/2008WO2008052072A2 Compounds for the treatment of pain and screening methods therefor
05/02/2008WO2008052044A2 Use of derivatives of propofol for treating diseases associated with oxidative stress
05/02/2008WO2008052005A2 Compounds and methods for treating estrogen receptor-related diseases
05/02/2008WO2008051942A2 Farnesoid x receptor agonists
05/02/2008WO2008051902A2 Method of restoring the incretin effect
05/02/2008WO2008051889A1 Rapid release mini-tablets provide analgesia in laboratory animals
05/02/2008WO2008051875A2 Adamantylurea compounds as soluble epoxide hydrolase inhibitors
05/02/2008WO2008051873A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors
05/02/2008WO2008051862A2 Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof
05/02/2008WO2008051826A2 Purines as pkc-theta inhibitors
05/02/2008WO2008051808A2 Bicyclic triazoles as protein kinase modulators
05/02/2008WO2008051799A2 Polyphenol-rich extract from plant material
05/02/2008WO2008051797A2 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
05/02/2008WO2008051794A2 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
05/02/2008WO2008051793A2 Method of preventing or treating metabolic syndrome
05/02/2008WO2008051763A1 Cathepsin proteases inhibitors
05/02/2008WO2008051760A2 Combination therapy for the treatment of pain
05/02/2008WO2008051759A1 Acetaminophen / ibuprofen combinations
05/02/2008WO2008051637A2 Pyridazinone compounds
05/02/2008WO2008051610A2 Treatment of impulse control disorders
05/02/2008WO2008051594A2 Anti-resorptive and bone building dietary supplements and methods of use
05/02/2008WO2008051586A2 Anti-resorptive and bone building dietary supplements and methods of use
05/02/2008WO2008051558A2 Isolated hydroxy and n-oxide metabolites and derivatives of o-desmethylvenlafaxine and methods of treatment
05/02/2008WO2008051547A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
05/02/2008WO2008051533A2 Benzimidazole compounds
05/02/2008WO2008051532A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
05/02/2008WO2008051531A2 Discontinuous methods of treating cancer
05/02/2008WO2008051525A2 Methods of treating ovarian cancer
05/02/2008WO2008051523A2 Carbazole derivatives useful as medicaments in cancer therapy
05/02/2008WO2008051514A2 Hcv ns3 protease inhibitors
05/02/2008WO2008051502A1 Purine derivatives for the treatment of cystic diseases
05/02/2008WO2008051494A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
05/02/2008WO2008051475A2 Hcv ns3 protease inhibitors
05/02/2008WO2008051465A2 Process for making crystalline anhydrous docetaxel
05/02/2008WO2008051461A2 Acne treatment composition and methods for using
05/02/2008WO2008051440A1 Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione
05/02/2008WO2008051416A2 Compounds that inhibit the activity of hsp90 for treating infections
05/02/2008WO2008051405A1 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/02/2008WO2008051404A2 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/02/2008WO2008051282A2 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine
05/02/2008WO2008051272A2 Somatostatin agonists
05/02/2008WO2008051190A2 Metallized nanostructured chemicals alloyed into polymers
05/02/2008WO2008051080A1 Skin cream comprising a combination of aloe vera and spermine
05/02/2008WO2008051017A1 A cleavage agent selectively acting on soluble assembly of amyloidogenic peptide or protein
05/02/2008WO2008050987A1 Combination formulation with controlled release comprising metformin and glimepiride
05/02/2008WO2008050916A1 Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(mci), and improvement of cognitive function
05/02/2008WO2008050899A1 Liquid koji and quick-fermented miso type food material
05/02/2008WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME
05/02/2008WO2008050896A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
05/02/2008WO2008050871A1 Crystalline carbapenem compounds
05/02/2008WO2008050858A1 Amide compound, salt thereof, and biofilm remover using them
05/02/2008WO2008050857A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof
05/02/2008WO2008050853A1 Therapeutic agents for irritable bowel syndrome
05/02/2008WO2008050848A1 Adhesive preparation
05/02/2008WO2008050836A1 Agent for ameliorating adverse side-effect of chemotherapeutic agent
05/02/2008WO2008050821A1 Indole compound
05/02/2008WO2008050808A1 2-aminoquinazoline derivative
05/02/2008WO2008050776A1 Ophthalmic aqeous liquid preparation
05/02/2008WO2008050732A1 Iminopyridine derivative and use thereof
1 ... 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 3290 3291 3292 3293 3294 3295 3296 3297 ... 7860